Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Vaccine|December 4, 2012
Modeling preventative strategies against human papillomavirus-related disease in developed countriesKaren Canfell, Harrell Chesson, Shalini L Kulasingam, et al.The Journal of Infectious Diseases|November 12, 2010
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findingsLaia Bruni, Mireia Diaz, Xavier Castellsagué, et al.European Journal of Public Health|April 24, 2018
Moving towards an organized cervical cancer screening: costs and impactMireia Diaz, David Moriña, Vanesa Rodríguez-Salés, et al.BMC Medical Research Methodology|January 7, 2021
Quantifying the under-reporting of uncorrelated longitudal data: the genital warts exampleDavid Moriña, Amanda Fernández-Fontelo, Alejandra Cabaña, et al.Vaccine|November 26, 2008
Mathematical models of cervical cancer prevention in Latin America and the CaribbeanSue J Goldie, Mireia Diaz, Dagna Constenla, et al.Vaccine|June 14, 2008
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesSue J Goldie, Meredith O'Shea, Nicole Gastineau Campos, et al.Molecules (Basel, Switzerland)|June 28, 2023
Modulation of Functional Phosphorylation Sites by Basic Residues in the Unique Domain of c-SrcAndras Lang, Alejandro Fernández, Mireia Diaz-Lobo, et al.Journal of Medical Economics|May 29, 2019
Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysisWadie Messoudi, Toufik Elmahi, Chakib Nejjari, et al.Vaccine|July 8, 2008
Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policyJane J Kim, Katie E Kobus, Mireia Diaz, et al.Vaccine|December 17, 2013
Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)Jane J Kim, Monisha Sharma, Meredith O'Shea, et al.Pageof 5